Intrathecal Baclofen Pump Therapy

Baclofen is a muscle-relaxant medication commonly used to treat spasticity. Taken as a tablet, baclofen has to travel through the bloodstream to reach the spinal cord, and the doses needed to control severe spasticity this way can cause significant side effects, particularly drowsiness and generalized weakness.

Intrathecal baclofen therapy delivers the same medication directly into the fluid surrounding the spinal cord (the cerebrospinal fluid), using a small pump implanted under the skin of the abdomen. Because the medication is delivered exactly where it is needed, much smaller doses can achieve a similar or better effect on spasticity, with substantially fewer systemic side effects than oral baclofen at the doses that would be required to achieve comparable control.

Intrathecal baclofen therapy is generally considered for patients with severe, generalized or regional spasticity, often affecting the legs and sometimes the trunk and arms, that has not been adequately controlled with oral medication, physical therapy and, where applicable, botulinum toxin injections. It is used in a range of conditions, including cerebral palsy, spinal cord injury, multiple sclerosis, and severe spasticity following brain injury.

Before a pump is implanted, most patients undergo a baclofen trial, in which a single test dose of baclofen is given directly into the spinal fluid (typically via a lumbar puncture) to assess how much the spasticity responds and whether side effects are well tolerated. This step is important because it demonstrates, in advance, whether intrathecal baclofen is likely to be beneficial for a given patient; it is not assumed automatically, even in patients with a strong clinical case for the therapy.

A pump is generally considered once oral medication and other conservative measures no longer provide adequate control of spasticity that is significantly affecting movement, comfort, positioning, caregiving or sleep, and once a baclofen trial has confirmed a meaningful response.

The pump is implanted under general anesthesia. A catheter is placed into the fluid space around the spinal cord and tunneled under the skin to connect to a small pump, which is implanted in a pocket created under the skin of the abdomen. The pump delivers baclofen continuously at a programmed rate, which can be adjusted from outside the body without further surgery.

• Detailed assessment of the pattern, severity and functional impact of spasticity
• Neurological examination, distinguishing spasticity from other causes of stiffness or reduced movement
• A baclofen trial to confirm likely benefit
• Assessment of general health and suitability for a minor surgical implant procedure
• Discussion of goals — for example, comfort and ease of care versus a specific functional goal such as improved transfers

Intrathecal baclofen therapy aims to reduce spasticity to a level that improves comfort, ease of positioning and caregiving, and, in some patients, function such as transfers or, occasionally, walking. Treatment goals vary between patients: for some, the priority is reduced pain and easier care; for others, it is improved active movement. Dosing is adjusted gradually after implantation to find the level that best matches each patient’s individual goals; the aim is not to eliminate all muscle tone, which itself can sometimes be functionally useful (for example, in supporting standing).

The pump’s medication reservoir needs to be refilled periodically, typically every one to six months, depending on the dose and reservoir size, via a simple needle procedure through the skin, without further surgery. Regular follow-up allows dosing to be adjusted over time as spasticity, function or goals change.

The pump contains a battery with a finite life, typically lasting several years depending on the model and dose used. When the battery nears the end of its life, the entire pump is replaced in a further surgical procedure; the spinal catheter usually does not need to be replaced at the same time unless there is a separate problem with it.

Possible complications include infection around the implant, catheter problems such as blockage, dislodgement or leakage of spinal fluid, and issues related to the medication itself. An overdose of intrathecal baclofen can cause excessive weakness, drowsiness, breathing difficulty or loss of consciousness, and is treated as a medical emergency. Abrupt withdrawal (for example, due to a pump malfunction or a catheter problem interrupting delivery) can cause a serious reaction, including high fever, muscle rigidity, and, in severe cases, life-threatening complications; this is why regular follow-up and rapid access to medical attention for any pump-related symptoms are essential parts of ongoing care.

Because the pump delivers a continuous, adjustable dose of a medication with serious risks at both excessive and insufficient levels, regular, scheduled follow-up is not optional. Patients and caregivers are given clear guidance on the warning signs of both overdose and withdrawal and how to seek urgent care if they occur, wherever they are.